Avon Products Inc. Message Board
-
He earned $2mm last year with salary, bonus etc. Not many CFO jobs that will earn him that much going forward. Always a red flag with the CFO walks out unexpectedly. This was a relatively easy CFO job; nothing overly complext about their accounting. If he leaves behind that pay package, those shares...no doubt that this is a huge red flag.
-
I agree with other poster that could be they have killed the MDTV deal so the prospect of Mandel having to manage anything else has been curtailed since he seems way over his head with what he has. How many Preferred issues are there? Selling notes directly to the public; increased credit line not finalized; This is a mañana stock...but it's mañana has not come yet ; )
-
I don't know what CC you listened too (or what stock chart you looked at to see how the market reacted to both the earnings report and the CC) ...but with possible negative free cash flow this year I doubt they will be buying back much stock or that whatever they could buy back will make much of a difference in the price. They have gone into "Missouri" territory with the market...which is "show me"...but the rest of this year is mucked up with more "restructuring expenses" etc. etc. Lots of smoke, lots of mirrors and no free cash flow. Oh...and lots of stock compensation for the top 5!!
-
You are all a bunch of losers. Go find a stock you can understand and buy it and hold it for years and you might make some money. This company has done a GREAT job for shareholders over the past 3 years by building a highly profitable, strong cash-generating business in a "hot" space and then have the financial skills to make a critical strategic acquisition. David Klein, on Seeking Alpha, wrote about this company last year in a highly detailed and very thoughful piece. It has been followed by several analysts in the M2M space (you probably don't even know that that is.) Well, find another board and kick your dog.
- Reply to
Ignore castemeoff=nekkidshort etc. Sicko, Whacko..Fired for Exposing Himself in Elevator
by swank818 •Apr 17, 2013 10:15 PMI don't know about exposing on an elevator, but his ignorance is OVER-exposed on this board for sure.
-
Big thrill to try and control a message board with scare tactics. Lawsuit over. Company makes piles of money and has piles of money on the balance sheet. Stock is up 25% in past few months. Good Bye, So Long, Farewell and don't waste your breath. Most people are now putting you on IGNORE (that is done for IGNORant posts)
- Reply to
No opinions just a Yahoo 2 year stock chart-Breaking through to the downside!!
by swank818 •Apr 5, 2013 4:37 AMI guess so
- Reply to
Cinryze Subcu Unlikely to enter market until 2016 or 2017...another mañana story!!
by audphil78 •Apr 5, 2013 4:34 AMThey have about 18 months runway before they start to run out of cash. If they get a few milestone payments they can probably eke out 24 months. I had thought they were going to sell their own direct product, but that never seems to have gained any real traction??
- Reply to
1/30 Jefferies reiterated its Underperform rating and $4.00 price target on Halozyme Therapeutics
by p8iano •Mar 13, 2013 10:29 PMHe got a lot of his stock at $1.75 and who knows whether he is a true believer or just keeping his LPs looking good by buying at higher prices to suck up stock?? All my opinion of course.
-
Amazing that they can't police this. What a disgrace.
-
Jefferies noted, “SC Herceptin EU approval is expected in 1H13; its commercial success will be key to ultimate validation of rHuPH20 technology & further valuation upside in HALO. We continue to view SC Herceptin commercial potential as low. Given delays in Herceptin biosimilar EU market entry & potentially expedited development of its T-DM1 in HER2+ BC adjuvant setting, Roche's focus on SC Herceptin seems to have diminished.”
-
Every 3-6 weeks he probably has a friend call in to ask about FTR just so he can blast it.